Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma

Gastroenterology
Hyung-Don KimSu-Hyung Park

Abstract

T-cell exhaustion, or an impaired capacity to secrete cytokines and proliferate with overexpression of immune checkpoint receptors, occurs during chronic viral infections but has also been observed in tumors, including hepatocellular carcinomas (HCCs). We investigated features of exhaustion in CD8+ T cells isolated from HCC specimens. We obtained HCC specimens, along with adjacent nontumor tissues and blood samples, from 90 patients who underwent surgical resection at Asan Medical Center (Seoul, Korea) from April 2016 through April 2018. Intrahepatic lymphocytes and tumor-infiltrating T cells were analyzed by flow cytometry. Tumor-infiltrating CD8+ T cells were sorted by flow cytometry into populations based on expression level of programmed cell death 1 (PDCD1 or PD1): PD1-high, PD1-intermediate, and PD1-negative. Sorted cells were analyzed by RNA sequencing. Proliferation and production of interferon gamma (IFNG) and tumor necrosis factor (TNF) by CD8+ T cells were measured in response to anti-CD3 and antibodies against immune checkpoint receptors including PD1, hepatitis A virus cellular receptor 2 (HAVCR2 or TIM3), lymphocyte activating 3 (LAG3), or isotype control. Tumor-associated antigen-specific CD8+ T cells were identi...Continue Reading

References

Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shawn D BlackburnE John Wherry
Jan 30, 2010·Bioinformatics·Aaron R Quinlan, Ira M Hall
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Feng ShiFu-Sheng Wang
May 11, 2011·The Journal of Clinical Investigation·Lukas BaitschDaniel E Speiser
Dec 8, 2011·Cancer Immunology, Immunotherapy : CII·Rui-Ru JiVafa Shahabi
Apr 17, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hang LiWeiping Zou
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jan 18, 2013·BMC Bioinformatics·Sonja HänzelmannJustin Guinney
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 24, 2015·Trends in Immunology·Kristen E Pauken, E John Wherry
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi
Jan 30, 2016·Nature Reviews. Cancer·Nicholas P RestifoAlexandra Snyder
Apr 16, 2016·Nature Reviews. Cancer·Suzanne L TopalianDrew M Pardoll
Jul 1, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julien CalderaroJean-Michel Pawlotsky
Nov 1, 2016·Nature Medicine·Ronald J HauseStephen J Salipante
Jun 18, 2017·Cell·UNKNOWN Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, UNKNOWN Cancer Genome Atlas Research Network
Jun 27, 2017·The Journal of Clinical Investigation·Mark AyersTerrill K McClanahan
Jan 9, 2018·Nature Medicine·Carsten KriegBurkhard Becher

❮ Previous
Next ❯

Citations

Jul 18, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Elisabetta Cariani, Gabriele Missale
Dec 1, 2019·Journal for Immunotherapy of Cancer·Jiaqiang MaXiaoming Zhang
Jul 30, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hyung-Don KimSu-Hyung Park
Aug 6, 2020·Journal for Immunotherapy of Cancer·Yang ShenLiusheng Peng
Mar 13, 2020·International Journal of Cancer. Journal International Du Cancer·Sarun JuengpanichXiujun Cai
Sep 18, 2020·Cellular and Molecular Life Sciences : CMLS·Yuan WeiDong-Ming Kuang
Nov 15, 2019·Cancer Immunology, Immunotherapy : CII·Bettina LanghansUlrich Spengler
Dec 4, 2019·Frontiers in Immunology·Meijuan Zheng, Zhigang Tian
Sep 4, 2020·International Journal of Molecular Sciences·Michela Guardascione, Giuseppe Toffoli
Mar 8, 2019·Archives of Pharmacal Research·Hyung-Don Kim, Su-Hyung Park
Oct 7, 2020·Cancers·Christo KoleDimitrios Schizas
Nov 17, 2020·Frontiers in Molecular Biosciences·Lei WuGuihai Zhang
Jan 17, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Minsuk KwonEui-Cheol Shin
Feb 7, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meng DuanQiang Gao
Jul 14, 2020·Seminars in Cancer Biology·Ombretta MelaiuFederica Gemignani
Sep 4, 2020·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hyung-Don KimChanghoon Yoo
Mar 29, 2019·Redox Biology·Sin Yee GunSiew Cheng Wong
Nov 15, 2020·Hepatology International·Cositha SanthakumarGeoffrey W McCaughan
Jan 1, 2021·International Journal of Molecular Sciences·Ji Won Han, Seung Kew Yoon
Dec 4, 2020·Journal for Immunotherapy of Cancer·Siwen Hu-LieskovanHolden T Maecker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.